Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival

BACKGROUND AND AIMS: Liver transplantation (LT) is the treatment of end‐stage non‐alcoholic liver disease (NAFLD), that is decompensated cirrhosis and/or complicated by hepatocellular carcinoma (HCC). Few data on long‐term outcome are available. The aim of this study was to evaluate overall patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Villeret, François, Dharancy, Sébastien, Erard, Domitille, Abergel, Armand, Barbier, Louise, Besch, Camille, Boillot, Olivier, Boudjema, Karim, Coilly, Audrey, Conti, Filomena, Corpechot, Christophe, Duvoux, Christophe, Faitot, François, Faure, Stéphanie, Francoz, Claire, Giostra, Emiliano, Gugenheim, Jean, Hardwigsen, Jean, Hilleret, Marie‐Noëlle, Hiriart, Jean‐Baptiste, Houssel‐Debry, Pauline, Kamar, Nassim, Lassailly, Guillaume, Latournerie, Marianne, Pageaux, Georges‐Philippe, Samuel, Didier, Vanlemmens, Claire, Saliba, Faouzi, Dumortier, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Metabolic & Toxic Liver Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804523/
https://www.ncbi.nlm.nih.gov/pubmed/35924452
http://dx.doi.org/10.1111/liv.15385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804523/
https://www.ncbi.nlm.nih.gov/pubmed/35924452
http://dx.doi.org/10.1111/liv.15385

Ejemplares similares